• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Biogen

Anonymous board for Biogen
Replies
25
Views
5K
Anonymous
Replies
0
Views
1K
Anonymous
Replies
7
Views
4K
Anonymous
Replies
0
Views
1K
Anonymous
Replies
2
Views
2K
Anonymous
Replies
1
Views
2K
Anonymous
Replies
12
Views
5K
Anonymous
Replies
11
Views
6K
Anonymous
Replies
2
Views
2K
Anonymous
Replies
12
Views
5K
Anonymous
Replies
1
Views
2K
Anonymous
Replies
2
Views
1K
Anonymous
157
Replies
0
Views
1K
Anonymous
Replies
6
Views
2K
Anonymous
Replies
1
Views
2K
Anonymous
Replies
9
Views
3K
Anonymous
Replies
6
Views
1K
Anonymous
Replies
4
Views
1K
Anonymous